You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: April 27, 2024

Robins Ah Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for ROBINS AH, and what generic and branded alternatives to ROBINS AH drugs are available?

ROBINS AH has ten approved drugs.



Summary for Robins Ah
US Patents:0
Tradenames:10
Ingredients:7
NDAs:10

Drugs and US Patents for Robins Ah

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Robins Ah ROBIMYCIN erythromycin TABLET, DELAYED RELEASE;ORAL 061633-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
Robins Ah ROBAXISAL aspirin; methocarbamol TABLET;ORAL 012281-001 Approved Prior to Jan 1, 1982 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for Robins Ah

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-001 Approved Prior to Jan 1, 1982 3,495,013 ⤷  Try a Trial
Robins Ah TENATHAN bethanidine sulfate TABLET;ORAL 017675-002 Approved Prior to Jan 1, 1982 3,495,013 ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration
Paragraph IV (Patent) Challenges for ROBINS AH drugs
Drugname Dosage Strength Tradename Submissiondate
➤ Subscribe Tablets 1 mg ➤ Subscribe 2009-08-14
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.